Diabetes Clinical Trials in Atlanta

Showing 61-80 of 475 trials

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

NCT05224258

This global study (US, Canada, and Australia) will evaluate the safety and effectiveness of the MiniMed 780G system in type 1 adult and pediatric subjects utilizing Fiasp (insulin aspart injection) in a home setting.

Type 1 Diabetes

Medtronic Diabetes240 participantsStarted Mar 2022

Little Rock, Arkansas, United States • Fresno, California, United States • Sacramento, California, United States +15 more locations

TERMINATEDPhase 2< 1 mile

A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

NCT04899271

The objective of this clinical trial was to assess whether ladarixin treatment is effective to improve glycemic control in newly diagnosed Type 1 Diabetes (T1D) adult patients with preserved β-cell function. The safety of ladarixin in the specific clinical setting was also evaluated.

New-onset Type 1 Diabetes

Dompé Farmaceutici S.p.A25 participantsStarted Dec 2020

Aurora, Colorado, United States • Atlanta, Georgia, United States • Jette, Belgium +13 more locations

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Diabetes Trials in Other Cities

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

FEED-Cystic Fibrosis (FEED-CF)

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

HbA1c Variation Study

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia

The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

Embecta AID System in Adults With Type 2 Diabetes

Other Conditions in Atlanta